Details
Vasocardin Indications
Arterial hypertension (to reduce blood pressure and risk of cardiovascular and coronary complications, as well as the risk of cardiovascular and coronary death, including sudden death).
Angina.
In order to decrease the mortality and frequency of reinfarction after the acute phase of myocardial infarction.
Cardiac arrhythmias, including supraventricular tachycardia, reduction of ventricular rate during atrial fibrillation and ventricular arrhythmia.
Migraine Prevention.
Dosage & Administration
Vasocardin indicated for daily administration, preferably in the morning. The tablet should be taken without chewing and drinking plenty of water. During the selection of the dose necessary to control the heart rate to prevent bradycardia. The maximum daily dose - 200 mg.
Arterial hypertension
The recommended dose of the drug for patients with mild or moderate form of hypertension is 50 mg 2 times a day. If this is not achieved dosing therapeutic effect, the dose can be increased to 100-200 mg 1 time per day, or combined with other antihypertensive agents.
Angina
The initial dose is 50 mg 2 times a day. If the dispensing therapeutic effect is not achieved, the dose can be increased up to 1 200 mg once a day. If necessary, the drug can be combined with other drugs for the treatment of angina.
To reduce the mortality and frequency reuse after the acute phase of myocardial infarction
After finishing the acute phase of myocardial infarction drug prescribed 100 mg 2 times a day.
Cardiac arrhythmias, including supraventricular tachycardia, reduction of ventricular rate during atrial fibrillation and ventricular Arrhythmias
The initial dose is 50 mg 2 times a day. If the dispensing therapeutic effect is not achieved, the daily dose can be increased to 200 mg, divided into 2 intakes, or combined with other antihypertensive agents.
Prophylaxis of migraine
The recommended daily dose - 100 mg of 1 or 2 times per day.
Contradictions
Hypersensitivity to any component of the drug or other β-adrenergic blockers;
AV-block (II and III), sinoatrial block;
syndrome sick sinus;
decompensated heart failure;
bradycardia (HR ≤50 beats / min.);
suspected acute myocardial infarction;
a state of shock;
severe peripheral circulatory disorders with pain or trophic changes;
hypotension (systolic blood pressure <100 mm Hg..);
asthma, severe chronic obstructive bronchopulmonary diseases;
metabolic acidosis;
simultaneous use of MAO inhibitors, except for type B MAO inhibitors (selergin);
pregnancy and breastfeeding;
child age.
